Combining Antiviral Pills With Experimental Drug Brequinar Effective in Treating COVID: Study

Combining Antiviral Pills With Experimental Drug Brequinar Effective in Treating COVID: Study
A COVID-19 treatment pill, called molnupiravir, developed by Merck & Co Inc. and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc., on Oct. 26, 2021. Merck & Co Inc./Reuters
|Updated:
Researchers have found that combining the antivirals remdesivir or molnupiravir with the experimental drug brequinar could be effective in treating the Chinese Communist Party (CCP) virus, which causes COVID-19.

The new drug combination was discovered by researchers at the University of Maryland School of Medicine (UMSOM) and the University of Pennsylvania Perelman School of Medicine.

Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics